Skip to main content

ADVERTISEMENT

Trial Data

Feature Interview
04/07/2016
In November 2015, BIOTRONIK announced that patients in European countries would now be able to benefit from the BioMonitor 2, a subcutaneous, insertable cardiac monitor. In August 2015, BIOTRONIK had announced CE approval and the results of a...
In November 2015, BIOTRONIK announced that patients in European countries would now be able to benefit from the BioMonitor 2, a subcutaneous, insertable cardiac monitor. In August 2015, BIOTRONIK had announced CE approval and the results of a...
In November 2015, BIOTRONIK...
04/07/2016
EP Lab Digest